Why is Natco Pharma falling/rising?

As of 25-Jul, Natco Pharma Ltd. is experiencing a decline in its stock price, currently at Rs 967.80, which reflects a decrease of Rs 29.9 or 3.0%. The stock has underperformed its sector by 2.7% today and has been on a consecutive downward trend for the last two days, resulting in a total drop of 5.99% during this period. Additionally, the stock's performance over the past week shows a decline of 6.48%, while its year-to-date performance is down 30.22%. Despite these short-term challenges, the company maintains a high management efficiency with a return on equity (ROE) of 15.57%, a low debt-to-equity ratio, and healthy long-term growth with operating profits increasing at an annual rate of 32.35%. The stock is also trading at a discount compared to its peers, which may indicate potential value for investors.
In the broader market context, the Sensex has only decreased by 0.36% over the past week, suggesting that Natco Pharma's decline is more pronounced than the overall market trend. The company's year-to-date performance of -30.22% starkly contrasts with the Sensex's gain of 4.25%, highlighting the stock's significant underperformance relative to the benchmark. However, the rising investor participation, evidenced by an 89.09% increase in delivery volume, indicates some interest in the stock despite its recent price drop. This suggests that while the stock is currently facing downward pressure, there may be underlying factors that could support a recovery in the future.